ABR-215757

Thuốc Gốc

Small Molecule

ABR-215757 is developed for the treatment of SLE (Systemic Lupus Erythematosus), which is an autoimmune disease. The disease affects mainly women of fertile age and progresses in flares with relatively symptom free periods in between. Current treatments of SLE are NSAID (nonsteroidal anti-inflammatory drugs), corticosteroids, antimalarians or cytotoxic drugs like for example Cyclophosphamide. The autoimmune attack affects several different organ systems and many patients suffer from serious secondary disease symptoms such as renal disorders as the disease progresses.

Chỉ Định : Investigated for use/treatment in rheumatoid arthritis and systemic lupus erythematosus.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05901

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading